Form 4: Director Giltner's UTHR Stock Vesting & RSU Award
Insider Transaction Report
United Therapeutics Director Richard Giltner reported the vesting of 1,190 restricted stock units and the award of 1,310 new restricted stock units.
Summary
- Director Richard Giltner reported transactions involving United Therapeutics Corporation (UTHR) common stock and restricted stock units.
- On July 25, 2025, 1,190 restricted stock units vested, converting into 1,190 shares of common stock.
- Following this vesting, Giltner's direct beneficial ownership of common stock increased to 20,574 shares.
- On July 24, 2025, Giltner received an annual non-employee director award of 1,310 restricted stock units.
- Each restricted stock unit represents the right to receive one share of United Therapeutics Corporation common stock upon vesting.
Sentiment
Score: 5
Explanation: The filing is a routine disclosure of insider equity transactions, specifically the vesting of restricted stock units and the grant of new awards to a director. It does not contain information that would significantly alter the company's financial outlook or strategic direction, thus indicating a neutral sentiment.
Positives
- Director Richard Giltner received an annual award of 1,310 restricted stock units, indicating continued compensation and alignment with shareholder interests.
- The vesting of 1,190 restricted stock units increased the director's direct beneficial ownership of common stock to 20,574 shares, demonstrating a continued equity stake in the company.
Negatives
- No direct sales of common stock were reported, but also no open market purchases beyond the RSU awards and vesting.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: Increased transparency regarding director equity holdings and compensation structure.
- Employees: No direct impact mentioned.
- Customers: No direct impact mentioned.
- Suppliers: No direct impact mentioned.
- Creditors: No direct impact mentioned.
Key Dates
| Date | Description |
|---|---|
| 07/24/2025 | Date of earliest transaction; acquisition of 1,310 Restricted Stock Units as an annual non-employee director award. |
| 07/25/2025 | Vesting date for 1,190 Restricted Stock Units, converting into common stock. |
| 07/09/2026 | Vesting date for the 1,310 Restricted Stock Units acquired on 07/24/2025. |
Keywords
United Therapeutics, UTHR, SEC Form 4, Insider Trading, Restricted Stock Units, Director Compensation, Stock Vesting, Equity Award
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.